South Dakota SB 154: prohibit pharmaceutical manufacturers from interfering in contracts between 340B entities and pharmacies and to provide a penalty therefor.

Status: Signed by the Governor on 2025-03-13 S.J. 528 (as of 2025-03-13)

State: South Dakota · Session: 2025 · Bill: SB 154

Subjects: Attorney's Fees, Food and Drugs, Insurance, Trade Regulation

Sponsors: Emery, Moore, Muckey, Perry, Reed, Rehfeldt, Roby, Sauder, Smith, Vilhauer, Wittman

View South Dakota SB 154 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.